logo

For the Inventor, By the Inventor

Omiya, Japan

Hiroshige Homma

This inventor holds 9 USPTO granted patents. Top assignee: Yamanouchi Pharmaceutical Company Ltd.. Active years: 1979-1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroshige Homma. Retrieved from https://idiyas.com/inventor/hiroshige-homma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 100.0

Average Co-Inventor Count = 5.2

ph-index = 3

Forward Citations = 55(Granted Patents)


Location History:

  • Omiya, JP (1979 - 1982)
  • Omiyu, JP (1982)
  • Saitama, JP (1987)

Company Filing History:

goldMedal9 out of 329 
 
Yamanouchi Pharmaceutical Company Ltd.
 patents

Years Active: 1979-1987

Loading Chart...
9 patents (USPTO):Explore Patents
1. 4636516 - 3,5-di-tert-butyl-4-hydroxyphenyl-substituted heterocyclic compounds (1987-01-13),
2. 4335129 - Thiazolo[3,2-6]isoquinolines, compositions and use thereof (1982-06-15),
3. 4329455 - 1,3-Oxazino(3,2-b)isoquinoline-6-ones (1982-05-11),
4. 4288438 - Nitrogen-containing heterocyclic ring derivatives and analgesic and (1981-09-08),
5. 4284778 - Nitrogen-containing heterocyclic ring derivatives (1981-08-18),
6. 4251533 - Nitrogen-containing heterocyclic compounds (1981-02-17),
7. 4198512 - 1-Oxo-1,2-dihydroisoquinoline derivatives (1980-04-15),
8. 4186200 - Novel fused derivatives of 2-pyridones (1980-01-29),
9. 4163844 - Nitrogen-containing heterocyclic compounds (1979-08-07),

Title: Hiroshige Homma: Innovator in Heterocyclic Compounds

Introduction

Hiroshige Homma is a notable inventor based in Omiya, Japan. He has made significant contributions to the field of chemistry, particularly in the development of heterocyclic compounds. With a total of nine patents to his name, his work has implications in various therapeutic areas.

Latest Patents

Among his latest patents is the invention of 3,5-di-tert-butyl-4-hydroxyphenyl-substituted heterocyclic compounds. These compounds exhibit anti-inflammatory, anti-pyretic, analgesic, anti-arthritic, and immunoregulatory activities, making them particularly useful as antirheumatics. Another significant patent involves thiazolo[3,2-6]isoquinolines, which are nitrogen-containing heterocyclic compounds with diverse applications in medicinal chemistry.

Career Highlights

Hiroshige Homma is currently associated with Yamanouchi Pharmaceutical Company Ltd., where he continues to innovate and develop new compounds. His extensive research has led to advancements in pharmaceutical formulations and therapeutic agents.

Collaborations

He has collaborated with notable coworkers such as Kazuo Kubo and Yasuo Isomura, contributing to a dynamic research environment that fosters innovation.

Conclusion

Hiroshige Homma's work in the field of heterocyclic compounds showcases his dedication to advancing pharmaceutical science. His contributions have the potential to impact various therapeutic areas significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…